Genomic approaches to explore susceptibility and pathogenesis of alcohol use disorder and alcohol-associated liver disease.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
02 Oct 2023
Historique:
received: 24 05 2023
accepted: 13 08 2023
medline: 5 10 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: aheadofprint

Résumé

Excessive alcohol use is a major risk factor for the development of an alcohol use disorder (AUD) and contributes to a wide variety of other medical illnesses, including alcohol-associated liver disease (ALD). Both AUD and ALD are complex and causally inter-related diseases, and multiple factors other than alcohol consumption are implicated in the disease pathogenesis. While the underlying pathophysiology of AUD and ALD is complex, there is substantial evidence for a genetic susceptibility of both diseases. Current genome wide association studies indicate that genes associated with clinical AUD only poorly overlap with genes identified for heavy drinking and, in turn, neither overlap with genes identified for ALD. Uncovering the main genetic factors will enable us to identify molecular drivers underlying the pathogenesis and discover potential targets for therapy and implement patient care early in disease progression. In this review, we described multiple genomic approaches and their implications to investigate the susceptibility and pathogenesis of both AUD and ALD. We concluded our review with a discussion of the knowledge gaps and future research on genomic studies in these two diseases.

Identifiants

pubmed: 37796138
doi: 10.1097/HEP.0000000000000617
pii: 01515467-990000000-00586
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA023722
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025208
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026264
Pays : United States

Informations de copyright

Copyright © 2023 American Association for the Study of Liver Diseases.

Auteurs

Trina M Norden-Krichmar (TM)

Department of Epidemiology and Biostatistics, University of California, Irvine, CA.

Daniel Rotroff (D)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.

Tae-Hwi Schwantes-An (TH)

Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.

Ramon Bataller (R)

Liver Unit, Institut of Digestive and Metabolic Diseases, Hospital Clinic, Barcelona, Spain.
Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS).

David Goldman (D)

Laboratory of Neurogenetics and Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.

Laura E Nagy (LE)

Center for Liver Disease Research, Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH.
Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH.
Department of Molecular Medicine, Case Western Reserve University, Cleveland, OH.

Suthat Liangpunsakul (S)

Division of Gastroenterology and Hepatology, Department of Medicine, Indianapolis, IN.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN; and.
Roudebush Veterans Administration Medical Center, Indianapolis, IN.

Classifications MeSH